Arkolith/Insider Trading/ANIP/Form 4

Lalwani Nikhil

PRESIDENT & CEO, DirectorANI PHARMACEUTICALS INC (ANIP) · full profile →Form 4 · filed Mar 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 28, 2026Tax withholding(F)12K$73.90$903K422K
Feb 26, 2026Grant(A)76K$77.15$5.8M434K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001822629-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML